Examination of the differences between sulforaphane and sulforaphene in colon cancer: A study based on

Lei Gao1,2, Fengying Du3, Jinshen Wang3

  • 1Institute of Quality Standard and Testing Technology for Agro-Products, Shandong Academy of Agricultural Sciences, Jinan, Shandong 250100, P.R. China.

Oncology Letters
|August 30, 2021
PubMed

Insights

Sulforaphane and sulforaphene, compounds from cruciferous vegetables, show antiproliferative effects on colon cancer cells. Next-generation sequencing revealed shared impacts on key signaling pathways, suggesting similar biological activities.

Area of Science:

  • Molecular Biology
  • Oncology
  • Nutritional Science

Background:

  • Sulforaphane and sulforaphene are isothiocyanate compounds found in cruciferous vegetables.
  • These compounds exhibit antiproliferative properties against colon cancer.
  • The precise molecular mechanisms underlying their effects on colon cancer remain largely unelucidated.

Purpose of the Study:

  • To investigate the molecular mechanisms of sulforaphane and sulforaphene in colon cancer.
  • To utilize next-generation sequencing (NGS) to analyze gene expression changes induced by these compounds.

Main Methods:

  • Cultured SW480 colon cancer cells with sulforaphane or sulforaphene (25 µmol/l).
  • Performed RNA extraction and NGS after 48-hour incubation.
  • Conducted data analyses including correlation, principal component, hierarchical clustering, and pathway enrichment (GO, KEGG).

Main Results:

  • Significant differential gene expression was observed: 873 probes for sulforaphene and 959 for sulforaphane compared to controls.
  • Both compounds affected p53, MAPK, FOXO, and estrogen signaling pathways.
  • Sulforaphane uniquely enriched the Wnt signaling pathway, while sulforaphene impacted ubiquitin-mediated proteolysis.

Conclusions:

  • Sulforaphane and sulforaphene demonstrate comparable biological activities on colon cancer cells.
  • These compounds may exert their effects through modulation of Wnt and estrogen signaling pathways, respectively.
  • Further research into these pathways could reveal novel therapeutic strategies for colon cancer.

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
94.3K
Sanger Sequencing01:57

Sanger Sequencing

DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
762.2K
RNA-seq03:21

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.6K